Evestia, Clinical

Evestia Clinical - the new brand identity for EMAS Pharma - launches today as a market leading pharmaceutical research specialist focussed on Clinical Trials in Oncology and Rare Diseases

Published on 08/07/2025 at 18:07 | prnewswire.co.uk

Evestia Clinical England United States of America United Kingdom

en | CA7609751028 | EVESTIA | boerse | 67919884 |